$OXIS completed an additional round of financing in the amount of $1.25 million and an earlier round of financing completed in July of $1.425 million, brings the total funding for 2014 to $2.675 million. According to $OXIS, it will use the proceeds to fund $OXIS activities related to the acquisition and/or licensing of cannabis related intellectual properties, marketing of $OXIS nutraceutical products. This is exactly what today's news provided to it's shareholders.